WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Summary of responses on a legislative proposal to combat counterfeit medicines for human use

Details
Research
30 June 2008
ECIn response to the public consultation on "Key ideas for better protection of patients against the risk of counterfeit medicines", the Commission received 123 contributions from stakeholders. Of these, 100 were from industry (pharmaceutical industry, distributors, suppliers of active ingredients, consultants), 15 from citizens, patient (groups), and academics, and 8 from health professionals, pharmacists and health insurers.
Read more ...

Information Technology Award Announced for Pharmacy in 2009

Details
Research
11 June 2008
First DataBank Europe (FDBE) in association with The Guild of Healthcare Pharmacists (GHP) and the UK Clinical Pharmacy Association (UKCPA) announced the 2009 FDBE/GHP/UKCPA Information Technology Award. The aim of the annual award, which is in its seventh year, is to encourage, support and promote information technology initiatives and best practice in the use of IT in hospital pharmacy.
Read more ...

European Medicines Agency recommends measures to manage contamination of heparin-containing medicine

Details
Research
06 June 2008
The European Medicines AgencyThe European Medicines Agency has reviewed the risks associated with the use of heparin medicinal products contaminated with oversulphated chondroitin sulphate (OSCS). Heparins are used to prevent and treat blood clots. They are used widely in patients who could have, or have had a heart attack, in patients who have undergone major surgery, or patients on dialysis.
Read more ...

New Efforts to Help Improve Medical Products for Patient Safety and Quality of Medical Care

Details
Research
26 May 2008
U.S. Food and Drug Administration (FDA)HHS Secretary Mike Leavitt announced efforts underway at the U.S. Food and Drug Administration (FDA) and the Centers for Medicare & Medicaid Services (CMS) that will complement each other to improve patient safety and the quality of medical care. "This initiative will tremendously increase the FDA's capacity to monitor the use of medical products on the market," Secretary Leavitt said.
Read more ...

Carbon nanotubes may cause cancer, study reveals

Details
Research
23 May 2008
A new study conducted by a team of UK and US scientists has revealed the carcinogenic potential of certain carbon nanotubes. In a paper published in Nature Nanotechnology on 20 May, the researchers describe asbestos-like features in long, multi-walled carbon nanotubes (MWCNTs), when they are inhaled in sufficient quantities.
Read more ...

UK parliament backs hybrid embryo research

Details
Research
22 May 2008
The UK Parliament has voted to allow the creation of embryos containing both human and animal genetic material for research purposes. As apart of a two-date debate on amendments to the Human Fertilisation and Embryology Bill, members of parliament voted 342 to 163 against an amendment to outlaw so-called hybrid or admixed embryos.
Read more ...

New Light on the Way Blood Vessels Grow

Details
Research
19 May 2008
New research conducted by a group of EU-funded researchers is shedding new light on the way blood vessels grow, overturning years of medical thought. The findings have important implications for the development of novel drugs to treat diseases such as cancer, many of which target the tumour's ability to grow its own blood vessels.
Read more ...

More Pharma News ...

  1. Scientists identify molecule behind fat deposition and insulin release
  2. Scientists solve mystery of why arsenic works in cancer drugs
  3. Innovative Medicines Initiative to give boost to Europe's pharmaceutical industry
  4. Survey Takes Pulse of eHealth in Europe and Prescribes Wider ICT use Among Doctors
  5. Ozmosis and the Doctor's Channel Revolutionize Online Medical Knowledge Exchange with Video Content
  6. New Drug Reference Application to Enable Access to Multilex DDF on the Move
  7. New DNA sequencing strategy could be vital during disease outbreak
  • Start
  • Prev
  • 296
  • 297
  • 298
  • 299
  • 300
  • 301
  • 302
  • 303
  • 304
  • 305
  • Next
  • End
Tahmeena

Business & Industry

  • AMJEVITA™ (adalimumab-atto), first biosimilar to Humira® now available in the United States
  • CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
  • Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above
  • Pfizer expands 'An Accord for a Healthier World' product offering to include full portfolio for greater benefit to 1.2 billion people in 45 lower-income countries
  • Acquisition of Neogene Therapeutics completed

Research & Development

  • Antidepressants used for chronic pain on the rise, but are they effective?
  • Keys to making immunotherapy work against pancreatic cancer found in tumor microenvironment
  • Discovery of anti-cancer chemistry makes skullcap fit for modern medicine
  • Coordination of COVID-19 vaccine clinical trials produces a 'treasure trove' of data and a model for the future
  • Power of cancer drugs may see boost by targeting newly ID'd pathway
  • A soybean protein blocks LDL cholesterol production, reducing risks of metabolic diseases
  • 500,000 missed out on blood pressure lowering drugs during pandemic

Conferences & Events

  • SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
  • SAE Media Group's 6th annual 3D Cell Culture Conference
  • CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
  • 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
  • CPHI Excellence in Pharma Award Winners 2022
  • CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
  • CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index

Regulatory Affairs

  • FDA grants Accelerated Approval for Alzheimer's disease treatment
  • FDA approves new HIV drug for adults with limited treatment options
  • FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
  • FDA approves first gene therapy to treat adults with Hemophilia B
  • FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
  1. You are here:  
  2. Home
  3. Research

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2023. All Rights Reserved.